|
|
Moderna, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Hiring plans These are clips from a Boston Business Journal article I found on Yahoo: Note the hiring for personalized cancer.......another hint that Moderna and MRK know a lot more about the P2 trial results than they have to date revealed to the public. " Moderna Inc. is hiring another 2,000 employees this year, a move that would massively grow its headcount — and most of them will be in Massachusetts. The Cambridge-based company (Nasdaq: MRNA) currently employs around 4,000 people globally, CEO Stephane Bancel told investors at the J.P. Morgan Healthcare Conference earlier this month, when he first announced the hiring plans. Chief human resources officer Tracey Franklin told the Business Journal that the majority of the new hires will be in Massachusetts, split between Cambridge and Norwood." portions omitted " The growth in headcount is slated to coincide with Moderna's next phase as a company. To date, Moderna's only commercial products are its Covid-19 vaccines, but that is likely to change in short order. Last week, Moderna said it planned to file for FDA approval of its new vaccine for respiratory syncytial virus, or RSV, for adults over 60 years old, based on trial data showing it was 84% effective at preventing lower respiratory tract diseases. And in December, the company announced positive results from a mid-stage trial of a personalized cancer vaccine it's developing with Merck & Co. (NYSE: MRK). The cancer vaccine is slated to enter a Phase 3 trial later this year. It is that drug that's underpinning much of the hiring plans, Franklin said. "I would say there's probably roughly around 1,000 that will be focused in personalized cancer, and manufacturing more broadly, including operations," she said. "Personalized cancer vaccine has a huge growth opportunity."" |
|
|
return to message board, top of board |
